Table 2.
Number of samples (N = 381), n (%) | |
---|---|
Age-group (WHO)* | |
Pediatrics | 16 (4.2) |
Adults | 365 (95.8) |
Gender | |
Male | 156 (40.9) |
Female | 225 (59.1) |
Ethnicity | |
Timorese | 348 (91.3) |
Others | 33 (8.7) |
Subdistrict group | |
Northern part | 226 (59.3) |
Southern part | 155 (40.7) |
Anemia status | |
Anemia† | 225 (59.1) |
Normal | 156 (40.9) |
Malaria infection (nested PCR) | |
P. falciparum | 57 (15.0) |
P. vivax | 95 (24.9) |
Mix (P. falciparum and P. vivax) | 29 (7.6) |
Noninfected | 200 (52.5) |
G6PD screening activity (Randox test)‡ | |
Normal | 285 (74.8) |
Deficient | 96 (25.2) |
G6PD = glucose 6-phosphate dehydrogenase; P. falciparum = Plasmodium falciparum; P. vivax = Plasmodium vivax.
Age-group (pediatrics ≤ 19 years and adults > 19 years).
Anemia (male < 13 g/dL and female < 11 g/dL).
G6PD screening activity (normal > 6.97 U/gHb and deficient ≤ 6.97 U/gHb).